People can wish well for people they see in the news and hope the get the vaccine. I do not recall people saying either of those persons received DCVax-L any more than they did for certain with King Charles. What they did see in this instance was coverage that utilized DCVax-L images and said Charles was not interested in traditional chemo but was interested in new treatments that had fewer side effects.
Reasonably, people would want to suggest DCVax-L here, given those factors and preferred parameters.
Of course in the case of people suffering from a brain tumor, investors would want patients to get the best, state of the art treatment even as a compassionate care treatment. People here believe in their investment, unless they are shorts.
Jimmy Carter had melanoma that spread. Those treatments have been successful with Melanoma, which has only limited antigen targets, so it is much easier to treat and not as heterogeneous in terms of antigen targets. So yeah, it’s much easier to treat with key drugs and he has done well. He did not have GBM, or the brain tumors targeted with DCVax-L so far.
None of this reflects on DCVax-L or investors, as much as you might like it to….
News 
Market Data 
Discover 
